Two Meningococcal B vaccines receive FDA, Breakthrough Therapy' designation

被引：0

|

作者：

不详

机构：

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014年 / 10卷 / 06期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：1428 / 1429

页数：2

相关论文

共 50 条

[1] Breakthrough-Therapy Designation - An FDA Perspective
Corrigan-Curay, Jacqueline
Mckee, Amy E.
Stein, Peter
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (15): : 1457 - 1458
[2] Rapastinel receives FDA breakthrough therapy designation
不详
[J]. NURSE PRACTITIONER, 2016, 41 (04): : 56 - 56
[3] FDA Approves Sovaldi for Chronic Hepatitis C (Drug Is Third With Breakthrough Therapy Designation to Receive Such Approval)
不详
[J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (05) : I - I
[4] Reflections on 10 years of the FDA's breakthrough therapy designation
Mullard, Asher
[J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) : 252 - 253
[5] Physician Perceptions of the FDA's Breakthrough Therapy Designation: An Update
Paquin, Ryan S.
Boudewyns, Vanessa
O'Donoghue, Amie C.
Aikin, Kathryn J.
[J]. ONCOLOGIST, 2022, 27 (01): : E85 - E88
[6] Two cancer immunotherapeutics received FDA's breakthrough designation
不详
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 809 - 809
[7] Reflections on 10 years of the FDA’s breakthrough therapy designation
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2022, 21 : 252 - 253
[8] FDA Grants Breakthrough Therapy Designation to Magrolimab for MDS Treatment
不详
[J]. ONCOLOGY-NEW YORK, 2020, 34 (10): : 430 - 430
[9] FDA Grants Breakthrough Therapy Designation to Tiragolumab Atezolizumab Therapy for Metastatic NSCLC
Slater, Hannah
[J]. ONCOLOGY-NEW YORK, 2021, 35 (02): : 76 - 76
[10] Expediting Drug Development - The FDA's New "Breakthrough Therapy" Designation
Sherman, Rachel E.
Li, Jun
Shapley, Stephanie
Robb, Melissa
Woodcock, Janet
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (20): : 1877 - 1880

← 1 2 3 4 5 →